Biomedical Catalyst
For developing innovative solutions to address health, and healthcare, challenges. Funds up to £2m.
Summary:
The aim of this industry-led R&D competition is to support SMEs to develop innovative solutions to address health, and healthcare, challenges.
Your project can focus on:
disease prevention and proactive management of health and chronic conditions
earlier and better detection and diagnosis of disease, leading to better patient outcomes
tailored treatments that either change the underlying disease or offer potential cures
transforming the delivery of healthcare
the development of digital health technologies
consumer focused self-care
This list is not exhaustive.
The industry led research and development (R&D) stream of the Biomedical Catalyst programme supports pre-market R&D projects. You must be able to demonstrate existing evidence of commercial and technical feasibility.
Your proposal must show how your project will improve the competitiveness and productivity of at least one UK SME partner involved in the project.
Project Size:
Your project must:
have total project costs between £150,000 and £4 million
not exceed a grant request of £2 million
have at least 50% of the total project costs shared by the SMEs, if collaborative
last between 6 months and 36 months
Scope:
The aim of this industry-led R&D competition is to support SMEs to develop innovative solutions to address health, and healthcare, challenges.
Your project can include:
experimental evaluation (at laboratory scale)
use of in vitro and in vivo models to evaluate proof of concept or safety
exploring potential production mechanisms
prototyping
product development planning
intellectual property protection
a demonstration of clinical utility and effectiveness
a demonstration of safety and efficacy (including phase 1 and phase 2 clinical trials)
regulatory planning
Themes:
Your project can focus on any health, or healthcare, sector or discipline including:
advanced therapies (including gene and cell therapies)
biosciences
preclinical technologies and drug target discovery
therapeutic and medicine development
diagnostics
medical technology and devices
precision medicine
digital health
independent living
This list is not intended to be exhaustive.